Why is a payday loan right for you Payday loan 50 up to
Payday loans uk

Countdown to a Cure

Posted on May 4, 2015 by in Destination: Cure, LifeGuide

LifeGuide [Destination: Cure] buy xanax online without prescriptionCountdown to a Cure amfAR CEO Kevin Frost discusses a new research initiative by Jeannie Wraight buy diazepam without prescription As part of the Countdown to a Cure Initiative, amfAR (The Foundation for AIDS Research) will direct $20 million, of a $100 million dollar investment, to launch the [...]

Equal HCV Treatment Benefits

Posted on April 29, 2015 by in Hep Talk, LifeGuide

LifeGuide [Hep Talk] Equal Treatment Studies show treatment parity among those living with HCV & HCV/HIV by Larry Buhl A press conference at the 2015 Conference on Retroviruses and Opportunistic Infections (CROI) offered two main takeaways: that the new generation of oral direct-acting antiviral agents (DAAs) are highly effective and safe, and that doctors can [...]

Making Space

Posted on April 20, 2015 by in LifeGuide

Vital Subjects by Keiko Lane, MFT Making Space What if the clinician forgets to ask? My partner sits on the table in our gynecologist’s office undressed for her annual exam. The hospital gown is flapping open around her back when our gynecologist says that given my partner’s age, health history, and low risk factors, she [...]

Silk-Protein Film

Posted on March 24, 2015 by in LifeGuide, Treatment Horizons

LifeGuide [Treatment Horizons] Blocking the First Step A silk-protein film aims to become an HIV prevention method by Chael Needle When we think of HIV prevention in sexually active individuals nowadays, the possibilities have moved beyond creating a latex barrier to pharmacological prophylaxis. For those living with HIV, this might mean suppressing the virus to [...]

Women & PrEP

Posted on March 16, 2015 by in Destination: Cure, LifeGuide

LifeGuide [Destination: Cure] It’s a Man’s World Research on women & PrEP needs to keep pace by Jeannie Wraight Whereas HIV cure and HIV prevention are two very different topics, I think it’s important to discuss the recent developments from the VOICE trial (women’s PrEP and microbicides study). With all the talk about PrEP, it’s [...]

Karyn Kaplan

Posted on March 13, 2015 by in Hep Talk, LifeGuide

LifeGuide [Hep Talk] Planting Seeds An activist shares grassroots strategies for making HCV treatment available worldwide by Larry Buhl Hepatitis treatment advocates identify three significant barriers to eradicating hepatitis C virus (HCV) in low-and middle-income countries: the lack of data necessary for development of policies, programs, and resource allocation; criminalization of people who inject drugs [...]

Military Medicine

Posted on March 4, 2015 by in LifeGuide, Under Reported

LifeGuide [Under Reported] Military Medicine Two leaders on the front lines of HIV research often go unrecognized by Mariel Selbovitz, MPH The U.S. is the global leader in the fight to end the AIDS crisis, funding seventy percent of all HIV treatment, care and prevention worldwide. Almost universally, when people think of the most important [...]

Is Mass HCV Screening the Best Approach?

Posted on February 23, 2015 by in Hep Talk, LifeGuide

LifeGuide [Hep Talk] Calling All Boomers New analysis questions the need for mass HCV screening by Larry Buhl In 2012, the U.S. Centers for Disease Control and Prevention (CDC) recommended screening everyone born between 1945 and 1965—the so-called Baby Boom generation—for the hepatitis C virus (HCV) whether or not they think they were exposed to [...]

The True End of AIDS

Posted on February 20, 2015 by in Destination: Cure, LifeGuide

LifeGuide [Destination: Cure] Trump Card Treatment and prevention are important, but an HIV cure will be the true end of AIDS by Jeannie Wraight Lately, we have been hearing a lot about the end of AIDS. Not by a cure but by targeted prevention and treatment measures to reduce the spread of HIV, including treatment [...]

Targeting Dual Points of Entry

Posted on February 18, 2015 by in LifeGuide, Treatment Horizons

LifeGuide [Treatment Horizons] Two Birds, One Stone Researchers make advances with agents that can target dual points of entry by Mariel Selbovitz, MPH Drug discovery and early to mid-stage drug development for HIV primarily takes place at academic institutions and small biotechnology companies. At the Frontiers in Developing Antiretroviral Therapy Conference (HIV DART 2014), which [...]